7 unchanged sentences
Form of Common Stock Certificate.
−Removed: Amended and Restated Investors’
−Removed: Rights Agreement, dated September 16, 2015, by and among Corvus Pharmaceuticals, Inc.
+Added: Amended and Restated Investors’ Rights Agreement, dated September 16, 2015, by and among Corvus Pharmaceuticals, Inc.
and the investors listed therein.
Form of Warrant
−Removed: Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
+Added: Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Open Market Sale Agreement, dated March 9, 2020, by and between Corvus Pharmaceuticals, Inc.
and Jefferies LLC.
+Added: Transition and Consulting Agreement, dated June 30, 2020 by and between Corvus Pharmaceuticals, Inc.
+Added: and Joseph Buggy
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
1 unchanged sentence
Certification required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
−Removed: XBRL Instance Document.
−Removed: XBRL Taxonomy Extension Schema Document.
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: XBRL Taxonomy Extension Definition Linkbase Document.
−Removed: XBRL Taxonomy Extension Label Linkbase Document.
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document.
+Added: XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
+Added: Inline XBRL Taxonomy Extension Schema Document.
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Definitions Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document.
+Added: The cover page of Corvus Pharmaceuticals, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, formatted in Inline XBRL (contained in Exhibit 101).
+Added: Indicates management contract or compensatory plan
The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Corvus Pharmaceuticals, Inc.
2 unchanged sentences
CORVUS PHARMACEUTICALS, INC.
−Removed: April 30, 2020
+Added: July 30, 2020
President, Chief Executive Officer and Director
(Principal Executive Officer)
−Removed: April 30, 2020
+Added: July 30, 2020
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.